Ostoskori 0 tavarat $0.00
Generic Vsmall (Vildagliptin)
Vsmall
Vsmall is an oral antidiabetic medication used to help control blood sugar levels in adults with type 2 diabetes mellitus. It contains vildagliptin, a DPP-4 inhibitor that improves insulin secretion and reduces glucose production in the liver.
Valikoi Annoskoot: 50mg
50mg
15pillerit
Vsmall $46.79
$38.99
$2.60 per pilleri
+ Paketin toimitus vakuutus
+ Seuraavat tilaukset 10% alennuksella
LISÄÄ OSTOSKORIIN
tallentaa: $0.00
50mg
30pillerit
Vsmall $79.19
$65.99
$2.20 per pilleri
+ Paketin toimitus vakuutus
+ Seuraavat tilaukset 10% alennuksella
LISÄÄ OSTOSKORIIN
tallentaa: $12.00
50mg
45pillerit
Vsmall $107.99
$89.99
$2.00 per pilleri
+ Paketin toimitus vakuutus
+ Seuraavat tilaukset 10% alennuksella
LISÄÄ OSTOSKORIIN
tallentaa: $27.00
50mg
90pillerit
Vsmall $206.39
$171.99
$1.91 per pilleri
+ Paketin toimitus vakuutus
+ Seuraavat tilaukset 10% alennuksella
LISÄÄ OSTOSKORIIN
tallentaa: $62.10
Tilauksesi pakataan turvallinen ja varma ja lähetetään 24 tunnin kuluessa. Tämä on täsmälleen miten pakettisi näyttää (kuvat todellinen merenkulku erä). Se on kooltaan ja ulkoasua säännöllisesti yksityinen kirje (9.4x4.3x0.3 tuumaa tai 24x11x0.7cm) ja se ei paljasta sen sisältöä
Maa Toimitustapa Toimitusajan Hinta  
Toimitus 14-21 päiviä 14.95$ Seuranta # saatavilla 4 päiviä
Toimitus 9-14 päiviä 30$ Seuranta # saatavilla 2 päiviä
Merenkulku maailmanlaajuisesti Luottamuksellisuus ja nimettömyys takaus
Turvallinen ja varma Huomaamaton näköinen paketit
Toimittavat tilauksia sisällä 24 tuntia 100% menestys toimitus
Suosittelut Tuotekuvaus
Tähän tuotteeseen liittyviä arvosteluja ei ole tällä hetkellä saatavilla, voit siis nyt ensimmäisenä lisätä oman arvostelusi tai lukea Suosituksia-sivulta lisää aiheeseen liittyvistä tuotteista.
Lisää Arvostelu

Common Use
Vsmall is used for the treatment of type 2 diabetes in adults when diet and exercise alone are not sufficient to control blood glucose levels. It may be prescribed as monotherapy or in combination with other antidiabetic medications such as metformin, sulfonylureas, or insulin. The drug helps improve glycemic control by enhancing the body’s natural response to meals.

Dosage and Direction
The usual recommended dose is 50 mg once or twice daily, depending on the treatment plan prescribed by the doctor. Tablets should be taken orally with or without food. Follow your healthcare provider’s instructions and do not change the dosage without medical advice.

Precautions
Before using Vsmall, inform your doctor if you have liver disease, kidney problems, heart failure, or a history of pancreatitis. Regular monitoring of blood glucose and liver function may be required during treatment. Maintain a healthy diet and exercise routine while using this medication.

Contraindications
Vsmall should not be used in patients with known hypersensitivity to vildagliptin or any component of the formulation. It is not recommended for the treatment of type 1 diabetes or diabetic ketoacidosis. Patients with severe liver impairment should avoid using this medication.

Possible Side Effects
Common side effects may include headache, dizziness, nausea, or mild gastrointestinal discomfort. Some patients may experience hypoglycemia when the drug is used with other antidiabetic agents. Rare but serious effects may include liver enzyme elevation or pancreatitis.

Drug Interaction
Vsmall may interact with other medications used to control blood sugar, increasing the risk of hypoglycemia. Certain drugs affecting liver function may also influence its metabolism. Inform your healthcare provider about all medicines, supplements, or herbal products you are taking.

Missed Dose
If you miss a dose, take it as soon as you remember. If it is almost time for the next scheduled dose, skip the missed dose and continue your regular schedule. Do not take a double dose to make up for the missed one.

Overdose
An overdose of Vsmall may increase the risk of side effects such as dizziness, nausea, or low blood sugar. Seek medical attention immediately if an overdose is suspected. Treatment is usually supportive and based on symptoms.

Storage
Store Vsmall at room temperature, away from moisture and direct sunlight. Keep the medication in its original packaging and out of reach of children. Do not use the product after the expiration date indicated on the package.

Disclaimer
We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.

Suosittelut
George Crant, Michigan, United States
Minun on pakko kommentoida tätä firmaa, sillä en voi sanoa muuta kuin että palvelunne on aivan parasta, jota olen saanut. Jos tulli vei tilaukseni, lähetitte aina uuden tilalle. Ainoa ongelma oli se, että tullin viedessä lähetyksen, he tiedustelivat minulta ...
lue lisää»
Geoffrey Stidworthy, EAST MELBOURNE, Australia
Pyydän anteeksi, en tiennyt että tuotteet lähetettiin erillisinä. Vastaanotin toisen kirjekuoren eilen. Kiitos avustanne ja tuestanne. Toivotan hyviä päivän jatkoja.
lue lisää»
Uutiset
Smart beds and motion sensors - is this the future of dementia care?
Jyoti and Bharat Patel are testing dementia technology including sensors in socks, their bed and around the house.
What food items should you stock up on in case of an emergency?
Extreme weather may be changing the way we need to shop, with the UK government urging people to stock up on canned goods.
Lindsay Clancy holdout juror says he had no doubt she deliberately killed her children
It is the first time the juror, who refused to side with the others and acquit Clancy, has spoken publicly about his decision.
Andy Burnham urged to set dementia waiting-time target
An 18‑week referral‑to‑treatment target has been backed by England's former national cancer director.
Toimitus Vaihtoehto